Discover

IRD
Opus Genetics, Inc.
4.14
8 x 4.14
4 x 4.15
bid
ask
-
0.04
0.84%
12:13 PM
timesize
Ytd106.22%
1y318.69%
4.13
day range
4.38
0.98
52 week range
5.81
Open4.20Prev Close4.18Low4.13High4.38Mkt Cap341.82M
Vol382.82KAvg Vol981.56KEPS-1.31P/EN/AForward P/E-1.20
Beta0.32Short Ratio4.69Inst. Own8.05%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg4.49200-d Avg3.271yr Est10.50
Income Statement
Total Revenue2.16M
Revenues (USD)2.16M
Gross Profit2.16M
Operating Expenses16.52M
Research and Development Expense10.58M
Selling, General and Administrative Expense5.94M
Operating Income-14.36M
Interest Expense69.00K
Net Income-65.53M
Net Income Common Stock-65.53M
Net Income Common Stock (USD)-65.53M
Consolidated Income-65.53M
Earnings per Basic Share-0.75
Earnings per Basic Share (USD)-0.75
Earnings per Diluted Share-0.75
Earning Before Interest & Taxes (EBIT)-65.47M
Earning Before Interest & Taxes (USD)-65.47M
Weighted Average Shares86.89M
Weighted Average Shares Diluted86.89M
Balance Sheet
Cash and Equivalents59.96M
Cash and Equivalents (USD)59.96M
Trade and Non-Trade Receivables2.72M
Current Assets66.60M
Property, Plant & Equipment Net186.00K
Total Assets66.79M
Current Liabilities9.34M
Total Liabilities87.89M
Accumulated Retained Earnings (Deficit)-254.12M
Shareholders Equity-45.84M
Shareholders Equity (USD)-45.84M
Assets Non-Current186.00K
Liabilities Non-Current78.55M
Trade and Non-Trade Payables4.42M
Cash Flow
Depreciation, Amortization & Accretion13.00K
Net Cash Flow from Financing27.60M
Net Cash Flow / Change in Cash & Cash Equivalents14.87M
Issuance (Purchase) of Equity Shares2.96M
Net Cash Flow from Operations-12.73M
Share Based Compensation1.46M